Cobalamins function as allosteric activators of an Angelman syndrome‐associated UBE3A/E6AP variant

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: ChemBioChem. Wiley. 2024, 25(10), e202400184. ISSN 1439-4227. eISSN 1439-7633. Verfügbar unter: doi: 10.1002/cbic.202400184

Event: Veröffentlichung

(where): Konstanz

(who): KOPS Universität Konstanz

(when): 2024

Creator: Müller, Franziska
Jansen, Jasmin
Offensperger, Fabian
Eichbichler, Daniela
Stengel, Florian
Scheffner, Martin

URN: urn:nbn:de:bsz:352-2-10r6gjgw872611

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:39 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Müller, Franziska
Jansen, Jasmin
Offensperger, Fabian
Eichbichler, Daniela
Stengel, Florian
Scheffner, Martin
KOPS Universität Konstanz

Time of origin

2024

Other Objects (12)

Cobalamins Function as Allosteric Activators of an Angelman Syndrome‐Associated UBE3A/E6AP Variant

Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Outcome measures in Angelman syndrome

Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase

A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry

Epilepsy in patients with Angelman syndrome

Sleep disturbance in Angelman syndrome patients

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84

Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome

Cortical and subcortical morphological alteration in Angelman syndrome

Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators

An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry

Cobalamins Function as Allosteric Activators of an Angelman Syndrome‐Associated UBE3A/E6AP Variant

Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Outcome measures in Angelman syndrome

Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase

A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry

Epilepsy in patients with Angelman syndrome

Sleep disturbance in Angelman syndrome patients

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84

Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome

Cortical and subcortical morphological alteration in Angelman syndrome

Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators

An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry

Cobalamins Function as Allosteric Activators of an Angelman Syndrome‐Associated UBE3A/E6AP Variant

Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Outcome measures in Angelman syndrome

Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase

A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry

Epilepsy in patients with Angelman syndrome

Sleep disturbance in Angelman syndrome patients

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84

Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome

Cortical and subcortical morphological alteration in Angelman syndrome

Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators

An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Cobalamins function as allosteric activators of an Angelman syndrome‐associated UBE3A/E6AP variant

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Cobalamins Function as Allosteric Activators of an Angelman Syndrome‐Associated UBE3A/E6AP Variant

Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Outcome measures in Angelman syndrome

Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase

A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry

Epilepsy in patients with Angelman syndrome

Sleep disturbance in Angelman syndrome patients

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84

Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome

Cortical and subcortical morphological alteration in Angelman syndrome

Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators

An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry

Cobalamins Function as Allosteric Activators of an Angelman Syndrome‐Associated UBE3A/E6AP Variant

Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Outcome measures in Angelman syndrome

Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase

A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry

Epilepsy in patients with Angelman syndrome

Sleep disturbance in Angelman syndrome patients

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84

Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome

Cortical and subcortical morphological alteration in Angelman syndrome

Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators

An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry

Cobalamins Function as Allosteric Activators of an Angelman Syndrome‐Associated UBE3A/E6AP Variant

Identification of Small-Molecule Activators of the Ubiquitin Ligase E6AP/UBE3A and Angelman Syndrome-Derived E6AP/UBE3A Variants

Outcome measures in Angelman syndrome

Gliflozins, sucrose and flavonoids are allosteric activators of lecithin-cholesterol acyltransferase

A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry

Epilepsy in patients with Angelman syndrome

Sleep disturbance in Angelman syndrome patients

On-target and off-target effects of novel orthosteric and allosteric activators of GPR84

Clinical, Molecular, and Neurophysiological Features in Angelman Syndrome

Cortical and subcortical morphological alteration in Angelman syndrome

Design, synthesis and evaluation of novel 3,5-disubstituted benzamide derivatives as allosteric glucokinase activators

An Overview of the Adaptive Behaviour Profile in Young Children with Angelman Syndrome: Insights from the Global Angelman Syndrome Registry

Related objects

Reset password